Delivery Order SPE2DE24D0013-SPE2D626F25D5
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc. was awarded a firm fixed-price delivery order valued at $1,750 by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This delivery order, issued under contract GXMRSA-NXG-10, requires performance in Sunnyvale, California, where Cepheid maintains its headquarters. The contract contains no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $9,216.80 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRSMVP-10 (Contract Number 4570254413), represents a continuation of the federal government's reliance on Cepheid's diagnostic capabilities. The contract utilizes no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,680 with an ultimate completion date of November 13, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued without a set-aside designation, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. As a manufacturer of advanced diagnostic systems and reagents, Cepheid supplies the federal...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $15,552.00 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 19, 2025. This delivery order, designated XPRS4PLEX-10, is for molecular diagnostic reagents and test cartridges to support the GeneXpert diagnostic platform. The contract utilizes no set-aside designation and reflects Cepheid's established position as a...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,597.30 under a Defense Logistics Agency Medical Supply Chain contract (4570223169). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 16, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F25D5Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, designated XPRSMVP-10, was issued without a set-aside designation and represents procurement of molecular diagnostic supplies and reagents for the GeneXpert diagnostic platform. The contract is performed at Cepheid's location in Sunnyvale, California, and falls under the Defense Logistics Agency's medical supply chain operations supporting federal healthcare and defense initiatives. Cepheid maintains an extensive federal contracting presence as the primary supplier of advanced molecular diagnostic systems and reagents across multiple defense and civilian healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with the VA valued at $6.7 million and $32.8 million respectively, which establish the framework for ongoing procurement of GeneXpert diagnostic cartridges and molecular testing solutions. Cepheid's core competency encompasses rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, tuberculosis, and other conditions, with all federal contracts utilizing firm fixed-price structures that reflect the company's competitive positioning in the federal molecular diagnostics procurement market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 12/15/25 |